Activation of Human Mesenchymal Stem Cells Impacts Their Therapeutic Abilities in Lung Injury by Increasing Interleukin (IL)-10 and IL-1RN Levels

Acute respiratory distress syndrome (ARDS) is an important cause of morbidity and mortality, with no currently effective therapies. Several preclinical studies have shown that human mesenchymal stem cells (hMSCs) have therapeutic potential for patients with ARDS because of their immunomodulatory pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bustos, Martha L., Huleihel, Luai, Meyer, Ernest M., Donnenberg, Albert D., Donnenberg, Vera S., Sciurba, Joseph D., Mroz, Lyle, McVerry, Bryan J., Ellis, Bryon M., Kaminski, Naftali, Rojas, Mauricio
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2013
Schlagworte:
Protocols and Manufacturing for Cell-Based Therapies
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3808203/
https://ncbi.nlm.nih.gov/pubmed/24089414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0033
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge